CD8A and neoplasm: Besides, after the usage of anti‐CD8 antibody to deplete CD8 T cells in 4T1 tumors, the tumor growth of 4T1 tumors was increased by IR‐TAM@Alb, RT, or co‐treated of IR‐TAM@Alb and RT when compared with the mice treated without CD8 depleting antibody (Figures S29 and S30, Supporting Information).